![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, February 09, 2021 8:08:40 PM
1. A message from a private company NeuroRx triggers a drop in PPS, affecting its Partner Relief Therapeutics Inc., which trades on the stock exchange.
2. NeuroRx has no obligations to RLF, but tries to merge with BRPA, who are the only beneficiaries of this agreement and currently without any obligation.
3. For its part, RLFTF will connect to ACER through merger.
4. While NeuroRx has no further obligations too and has to wait for RLF-100 /(Avaptadil) to receive an EUA, their CEO, JJ, can make any statements to manipulate the market at his believe.
5. The credibility can be seen in the reaction of the small investors of RLF/RLFTF and BRPA.
6. Which performance is actually available can be seen out of the volatility (see above).
7. ....and, after price manipulation, investors are recruited again !
(see the link):
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM